Neau G, Fadel E, Perros F, Boonstra A, Postmus PE, van

Neau G, Fadel E, Perros F, Boonstra A, Postmus PE, van der Velden J, Vonk-Noordegraaf A, Humbert M, Eddahibi S, Guignabert C: Dysregulated renin-angiotensin-aldosterone technique contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med 2012, 186:78089. Ullian ME, Gelasco AK, Fitzgibbon WR, Beck CN, Morinelli TA: N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells. J Am Soc Nephrol 2005, 16:2346353. Han WQ, Zhu DL, Wu LY, Chen QZ, Guo SJ, Gao PJ: N-acetylcysteine-induced vasodilation entails voltage-gated potassium channels in rat aorta. Life Sci 2009, 84:73237. Probyn ME, Cock ML, Duncan JR, Tolcos M, Hale N, Shields A, Rees SM, Harding R: The anti-inflammatory agent N-acetyl cysteine exacerbates endotoxin-induced hypoxemia and hypotension and induces polycythemia in the ovine fetus. Neonatology 2010, 98:11827. Voelkel NF, Bogaard HJ, Al Husseini A, Farkas L, Gomez-Arroyo J, Natarajan R: Antioxidants for the remedy of sufferers with serious angioproliferative pulmonary hypertension Antioxid Redox Signal 2013, 18:1810817.42. Gomez-Arroyo J, Mizuno S, Szczepanek K, Van Tassell B, Natarajan R, dos Remedios CG, Drake JI, Farkas L, Kraskauskas D, Wijesinghe DS, Chalfant CE, Bigbee J, Abbate A, Lesnefsky EJ, Bogaard HJ, Voelkel NF: Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.DMPG Protocol Circ Heart Fail 2013, 6:13644. 43. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR: Adjustments in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 1997, 100:2315324. 44. Baicu CF, Stroud JD, Livesay VA, Hapke E, Holder J, Spinale FG, Zile MR: Alterations in extracellular collagen matrix alter myocardial systolic efficiency. Am J Physiol Heart Circ Physiol 2003, 284:H122 132. 45. Takimoto E, Kass DA: Part of oxidative pressure in cardiac hypertrophy and remodeling. Hypertension 2007, 49:24148. 46. Redout EM, Wagner MJ, Zuidwijk MJ, Boer C, Musters RJ, van Hardeveld C, Paulus WJ, Simonides WS: Right-ventricular failure is related to improved mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res 2007, 75:77081. 47. Giordano FJ: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:50008. 48. Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ, Nicolls MR: Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J 2012, 40:1555565. 49. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A: Prognostic worth of ideal ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.Delta-Tocopherol In Vitro Eur Heart J 2007, 28:1250257.PMID:23074147 doi:10.1186/1465-9921-15-65 Cite this article as: Chaumais et al.: N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats. Respiratory Analysis 2014 15:65.Submit your next manuscript to BioMed Central and take full benefit of:Hassle-free on the net submission Thorough peer evaluation No space constraints or colour figure charges Quick publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Analysis which is freely out there for redistributionSubmit your manuscript at www.biomedcentral/submi.